These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31684193)

  • 1. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents.
    Garrido-Navas C; de Miguel-Perez D; Exposito-Hernandez J; Bayarri C; Amezcua V; Ortigosa A; Valdivia J; Guerrero R; Garcia Puche JL; Lorente JA; Serrano MJ
    Cells; 2019 Nov; 8(11):. PubMed ID: 31684193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological significance of circulating tumor cells in cancer.
    Masuda T; Hayashi N; Iguchi T; Ito S; Eguchi H; Mimori K
    Mol Oncol; 2016 Mar; 10(3):408-17. PubMed ID: 26899533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-mediated tumor metastasis mechanism and the role of cell adhesion molecules.
    Liu Y; Zhang Y; Ding Y; Zhuang R
    Crit Rev Oncol Hematol; 2021 Nov; 167():103502. PubMed ID: 34662726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology and clinical potential of circulating tumor cells.
    Lozar T; Gersak K; Cemazar M; Kuhar CG; Jesenko T
    Radiol Oncol; 2019 May; 53(2):131-147. PubMed ID: 31104002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumor cells and their advances to promote cancer metastasis and relapse, with focus on glioblastoma multiforme.
    Chistiakov DA; Chekhonin VP
    Exp Mol Pathol; 2018 Oct; 105(2):166-174. PubMed ID: 30028961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgery-mediated tumor-promoting effects on the immune microenvironment.
    Cheng X; Zhang H; Hamad A; Huang H; Tsung A
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):408-419. PubMed ID: 35066156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating and disseminated tumor cells: diagnostic tools and therapeutic targets in motion.
    Wang H; Stoecklein NH; Lin PP; Gires O
    Oncotarget; 2017 Jan; 8(1):1884-1912. PubMed ID: 27683128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival Mechanisms and Influence Factors of Circulating Tumor Cells.
    Wang WC; Zhang XF; Peng J; Li XF; Wang AL; Bie YQ; Shi LH; Lin MB; Zhang XF
    Biomed Res Int; 2018; 2018():6304701. PubMed ID: 30515411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy.
    Zhong X; Zhang H; Zhu Y; Liang Y; Yuan Z; Li J; Li J; Li X; Jia Y; He T; Zhu J; Sun Y; Jiang W; Zhang H; Wang C; Ke Z
    Mol Cancer; 2020 Jan; 19(1):15. PubMed ID: 31980023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J; Cao SW; Cai Z; Zheng L; Wang Q
    Cancer Biomark; 2017 Dec; 20(4):487-498. PubMed ID: 28869439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cell-blood cell crosstalk: Biology and clinical relevance.
    Pereira-Veiga T; Schneegans S; Pantel K; Wikman H
    Cell Rep; 2022 Aug; 40(9):111298. PubMed ID: 36044866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrid epithelial/mesenchymal phenotype(s): The 'fittest' for metastasis?
    Jolly MK; Mani SA; Levine H
    Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):151-157. PubMed ID: 29997040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cells-directed therapies target circulating tumor cells and metastasis.
    Dianat-Moghadam H; Mahari A; Heidarifard M; Parnianfard N; Pourmousavi-Kh L; Rahbarghazi R; Amoozgar Z
    Cancer Lett; 2021 Jan; 497():41-53. PubMed ID: 32987138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steps in metastasis: an updated review.
    Majidpoor J; Mortezaee K
    Med Oncol; 2021 Jan; 38(1):3. PubMed ID: 33394200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinical relevance of epithelial and mesenchymal markers in circulating tumor cells from colorectal cancer.
    Zhao R; Cai Z; Li S; Cheng Y; Gao H; Liu F; Wu S; Liu S; Dong Y; Zheng L; Zhang W; Wu X; Yao X
    Oncotarget; 2017 Feb; 8(6):9293-9302. PubMed ID: 28030836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
    Lu Y; Lian S; Ye Y; Yu T; Liang H; Cheng Y; Xie J; Zhu Y; Xie X; Yu S; Gao Y; Jia L
    Pharmacol Res; 2019 Jan; 139():535-549. PubMed ID: 30366102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.